Citadel Advisors
SURF

Citadel Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Citadel Advisors’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-118,652
Closed -$82.9K – 15589
2023
Q1 		$82.9K Sell
118,652
-492,555
-81% -$399K ﹤0.01% 11511
2022
Q4 		$501K Sell
611,207
-780,029
-56% -$769K ﹤0.01% 8228
2022
Q3 		$1.45M Buy
1,391,236
+11,890
+0.9% +$19K ﹤0.01% 6223
2022
Q2 		$2.26M Sell
1,379,346
-25,870
-2% -$53.7K ﹤0.01% 5302
2022
Q1 		$4.13M Sell
1,405,216
-36,820
-3% -$129K ﹤0.01% 4547
2021
Q4 		$6.89M Sell
1,442,036
-15,607
-1% -$101K ﹤0.01% 3743
2021
Q3 		$11M Sell
1,457,643
-343,445
-19% -$2.2M ﹤0.01% 2916
2021
Q2 		$13.4M Buy
1,801,088
+855,239
+90% +$6.59M ﹤0.01% 2619
2021
Q1 		$7.38M Buy
945,849
+887,474
+1,520% +$8.87M ﹤0.01% 3475
2020
Q4 		$539K Buy
+58,375
New +$507K ﹤0.01% 8000
2020
Q2 		– Sell
-282,130
Closed -$528K – 10699
2020
Q1 		$528K Sell
282,130
-1,465
-0.5% -$3.86K ﹤0.01% 6378
2019
Q4 		$533K Buy
283,595
+941
+0.3% +$1.57K ﹤0.01% 6717
2019
Q3 		$402K Sell
282,654
-14,467
-5% -$31.6K ﹤0.01% 7125
2019
Q2 		$838K Sell
297,121
-151,712
-34% -$604K ﹤0.01% 5986
2019
Q1 		$2.14M Sell
448,833
-245,961
-35% -$1.21M ﹤0.01% 4348
2018
Q4 		$2.95M Sell
694,794
-363,458
-34% -$2.81M ﹤0.01% 3541
2018
Q3 		$11.6M Buy
1,058,252
+192,533
+22% +$2.26M 0.01% 1942
2018
Q2 		$14.1M Buy
+865,719
New +$12.5M 0.01% 1609

Other funds holding SURF

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's SURF Position: Q2 2023 in Review

Citadel Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 118,652 shares — an estimated $82.9K sold.

Citadel Advisors first reported a position in SURF in Q2 2018 and held it in 18 quarters. The position peaked at $14.1M in Q2 2018. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Citadel Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 118,652 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $82.9K.
  • Citadel Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • Citadel Advisors's Surface Oncology, Inc. Common Stock position peaked at $14.1M in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.